Jeffrey Lieberman Selected Research

Perphenazine (Trilafon)

5/2011	The association between weight change and symptom reduction in the CATIE schizophrenia trial.
1/2010	Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: impact of race and smoking.
4/2008	Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia.
4/2007	Second-generation antipsychotics: reviewing the cost-effectiveness component of the CATIE trial.
12/2006	Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey Lieberman Research Topics

Disease

37	Schizophrenia (Dementia Praecox) 01/2022 - 01/2002
5	Tardive Dyskinesia 08/2013 - 01/2002
5	Weight Gain 08/2013 - 01/2009
4	Psychotic Disorders (Schizoaffective Disorder) 03/2017 - 04/2003
2	Obesity 03/2013 - 01/2011
2	Treatment-Resistant Schizophrenia 07/2012 - 01/2002
2	Mental Disorders (Mental Disorder) 01/2011 - 04/2003
1	Neurodevelopmental Disorders 01/2022
1	Substance-Related Disorders (Drug Abuse) 04/2015
1	Alzheimer Disease (Alzheimer's Disease) 04/2012
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2011
1	Cognitive Dysfunction 01/2011
1	Body Weight (Weight, Body) 01/2011
1	Psychomotor Agitation (Akathisia) 08/2009
1	Depressive Disorder (Melancholia) 12/2007
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2003

Drug/Important Bio-Agent (IBA)

26	Antipsychotic Agents (Antipsychotics)IBA 06/2017 - 01/2002
7	Biological ProductsIBA 06/2017 - 04/2003
7	Olanzapine (Zyprexa)FDA Link 03/2013 - 12/2006
5	Perphenazine (Trilafon)FDA LinkGeneric 05/2011 - 12/2006
4	ziprasidone (Geodon)FDA Link 05/2011 - 12/2006
3	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2011 - 12/2006
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2011
2	Proteins (Proteins, Gene)FDA Link 03/2013 - 10/2006
2	Haloperidol (Haldol)FDA LinkGeneric 03/2013 - 05/2011
2	Quetiapine Fumarate (Seroquel)FDA Link 05/2011 - 04/2008
2	Pharmaceutical PreparationsIBA 08/2009 - 05/2003
2	GTP-Binding Proteins (G-Protein)IBA 04/2008 - 01/2008
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 04/2007 - 10/2006
1	Sp4 Transcription FactorIBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Ketamine FDA LinkGeneric 01/2019
1	CannabinoidsIBA 03/2017
1	Illicit Drugs (Recreational Drugs)IBA 04/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2013
1	Serotonin ReceptorsIBA 03/2013
1	davunetideIBA 04/2012
1	Peptides (Polypeptides)IBA 04/2012
1	CholesterolIBA 05/2011
1	Triglycerides (Triacylglycerol)IBA 05/2011
1	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 01/2011
1	dihydrexidineIBA 01/2011
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2010
1	Capsules (Microcapsules)IBA 08/2009
1	RGS ProteinsIBA 04/2008
1	Antidepressive Agents (Antidepressants)IBA 12/2007
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2002
1	PlasticsIBA 05/2002
1	Clozapine (Clozaril)FDA LinkGeneric 01/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 04/2007 - 01/2002
1	Therapeutics 05/2011